All News #Library
Others
PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell
22 Sep 2022 //
BUSINESSWIRE
Oxford spinout raises $113M in bid to beat Sarepta`s Exondys 51 in DMD
05 Aug 2021 //
ENDPTS

Market Place
Sourcing Support